A industry association that represents drug testing companies and a cannabis-focused biopharmaceutical corporation are asking a federal appeals court to block the Trump administration from moving forward with federal marijuana rescheduling while ongoing litigation challenging the reform is considered—claiming that cannabis is a “dangerous drug that destroys lives.” The National Drug and Alcohol Screening Association…...
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
